Summary:
A 5 month study to determine effects of an investigative medicine on morning testosterone and reproductive status in men with secondary hypogonadism compared with Testim or placebo.
Qualified Participants Must:
• Be 21 to 64 years of age
•
Have been told you have secondary hypogonadism with low morning testosterone
•
Be willing to use a double-barrier form of birth control for the length of the study
Qualified Participants May Receive:
Study related lab work, medical care and medications. You may also be compensated for your participation.